The World Health Assembly is the highest decision-making body of the World Health Organization (WHO). It convenes every spring in Geneva, this year from 21 to 30 May. On this occasion, it has confirmed Switzerland's mandate on the WHO Executive Board from 2023 to 2026.
The World Health Assembly is the decision-making body of WHO. It is held every year in Geneva. As a full member, Switzerland participates, in the same way as all other 193 Member States. The main functions of the World Health Assembly are to determine the policies of the organization, appoint the Director-General, supervise financial policies, and revise and approve the proposed programme budget.
Nora Kronig appointed to the Executive Board
The Executive Board is composed of 34 members with expertise in the health sector, each elected for a three-year term. Switzerland previously held a seat on the Executive Board from 1999 to 2022 and from 2011 to 2014. It will do so again from May 2023 to 2026, represented by Ambassador Nora Kronig, Head of the FOPH’s International Affairs Division.
A seat on the WHO Executive Board allows Switzerland to bring to bear its interests and point of view. Thanks to its excellent health system, its globally leading research institutes, and its innovative pharmaceutical, biotechnology and medical technology companies, it can play an important part in strengthening global healthcare. In addition, the mandate on the Executive Board gives Switzerland a better insight into global health.
In the period from 2023 to 2026, Switzerland aims to help ensure that all countries are better prepared for health crises. Specifically, this extends to their ability to examine their own health status and to benefit from the experience of other countries. What is more, the improvement of existing platforms will facilitate the quick and reliable exchange of information between countries. This will allow more effective responses to health challenges both in normal circumstances and in times of crisis.
Last modification 14.07.2023